News and Events
08/23/08Anginera featured on ABC News
Courtesy KGO, Ch.7, San Francisco.
07/30/08
AHA Release: Patch May Prevent Heart Failure
after Heart Attack
12/05/07
Theregen Completes Phase I Enrollment
07/24/07
Theregen Launches Second Phase I Study
06/07/07
Paul Quadros is Theregen's new CEO
05/10/06
Anginera™ in first patient – press kit
(2.4 megabytes)
02/07/06
Theregen announces equity investment from Guidant Corporation to develop Anginera™ epicardial patch
01/23/06
Cell Therapy News – Human Cells Applied as Patch Improve Cardiac Function After Heart Attack, According to a Report in Tissue Engineering
01/17/06
Theregen receives $1.5 million from Sanderling Ventures To Conduct Anginera Phase I Trial